Concurrent and predictive validity of the Alberta Infant Motor Scale and the Peabody Developmental Motor Scales-2 administered to infants born preterm in Norway

Abstract Background The correlation between the Alberta Infant Motor Scale (AIMS) and the Peabody Developmental Motor Scales-2 (PDMS-2) has not previously been assessed in Norwegian infants. Our purpose was to investigate the concurrent validity of the AIMS and the PDMS-2 in a group of high-risk inf...

Full description

Bibliographic Details
Main Authors: Tordis Ustad, Merethe Brandal, Suzann K. Campbell, Gay L. Girolami, Charlotte Sinding-Larsen, Gunn Kristin Øberg
Format: Article
Language:English
Published: BMC 2023-11-01
Series:BMC Pediatrics
Subjects:
Online Access:https://doi.org/10.1186/s12887-023-04402-6
_version_ 1797451479520378880
author Tordis Ustad
Merethe Brandal
Suzann K. Campbell
Gay L. Girolami
Charlotte Sinding-Larsen
Gunn Kristin Øberg
author_facet Tordis Ustad
Merethe Brandal
Suzann K. Campbell
Gay L. Girolami
Charlotte Sinding-Larsen
Gunn Kristin Øberg
author_sort Tordis Ustad
collection DOAJ
description Abstract Background The correlation between the Alberta Infant Motor Scale (AIMS) and the Peabody Developmental Motor Scales-2 (PDMS-2) has not previously been assessed in Norwegian infants. Our purpose was to investigate the concurrent validity of the AIMS and the PDMS-2 in a group of high-risk infants, and to investigate the predictive validity of the two tests for atypical motor function at 24 months post term age (PTA). Methods This is a retrospective study of the AIMS and the PDMS-2 administered to infants born preterm with gestational age ≤ 32 weeks (n = 139) who had participated in a randomized controlled trial of early parent-administered physiotherapy. The infants’ motor development had been assessed using the AIMS and the PDMS-2 at 6- and 12-months. The primary outcome was PDMS-2 at 24-months PTA. To explore the correlation between the two tests we used Spearman’s rho. Bland Altman plots were used to detect if there were systematic differences between the measurements. Receiver-operating characteristics curves were used to calculate area under the curve as an estimate of diagnostic accuracy of the AIMS and the PDMS- with respect to motor outcome at 24 months. Results The correlation between the AIMS and the PDMS-2 (total motor and locomotion subscale), at 6 months, was r = 0.44 and r = 0.76, and at 12 months r = 0.56 and r = 0.80 respectively. The predictive validity for atypical motor function at 24 months, assessed using the area under the curve at 6- and at 12- months, was for the AIMS 0.87 and 0.86, respectively, and for the PDMS-2 locomotion subscale 0.82 and 0.76 respectively. Conclusion The correlation between the AIMS and the PDMS-2 locomotion subscale, at 6- and 12- months PTA, was good to excellent in a group of infants born preterm in Norway. And the AIMS and the locomotion subscale of the PDMS-2 were equally good predictors for atypical motor outcomes at 24 months PTA. These findings indicate that the AIMS and the locomotion subscale of the PDM-2, could be used interchangeable when assessing motor development in infants at 6- or 12 months of age. Trial registration ClinicalTrials.gov NCT01089296.
first_indexed 2024-03-09T14:55:15Z
format Article
id doaj.art-7170ebeb6e444c69be13c27c760ec3e1
institution Directory Open Access Journal
issn 1471-2431
language English
last_indexed 2024-03-09T14:55:15Z
publishDate 2023-11-01
publisher BMC
record_format Article
series BMC Pediatrics
spelling doaj.art-7170ebeb6e444c69be13c27c760ec3e12023-11-26T14:15:09ZengBMCBMC Pediatrics1471-24312023-11-0123111110.1186/s12887-023-04402-6Concurrent and predictive validity of the Alberta Infant Motor Scale and the Peabody Developmental Motor Scales-2 administered to infants born preterm in NorwayTordis Ustad0Merethe Brandal1Suzann K. Campbell2Gay L. Girolami3Charlotte Sinding-Larsen4Gunn Kristin Øberg5Clinic of Rehabilitation, St. Olavs Hospital, Trondheim University Hospital, St. Olavs HospitalClinic of Rehabilitation, St. Olavs Hospital, Trondheim University Hospital, St. Olavs HospitalDepartment of Physical Therapy, College of Applied Health Sciences, University of Illinois at ChicagoDepartment of Physical Therapy, College of Applied Health Sciences, University of Illinois at ChicagoSection of Physiotherapy, Oslo University Hospital, UllevålDepartment of Clinical Therapeutic Services, University Hospital North NorwayAbstract Background The correlation between the Alberta Infant Motor Scale (AIMS) and the Peabody Developmental Motor Scales-2 (PDMS-2) has not previously been assessed in Norwegian infants. Our purpose was to investigate the concurrent validity of the AIMS and the PDMS-2 in a group of high-risk infants, and to investigate the predictive validity of the two tests for atypical motor function at 24 months post term age (PTA). Methods This is a retrospective study of the AIMS and the PDMS-2 administered to infants born preterm with gestational age ≤ 32 weeks (n = 139) who had participated in a randomized controlled trial of early parent-administered physiotherapy. The infants’ motor development had been assessed using the AIMS and the PDMS-2 at 6- and 12-months. The primary outcome was PDMS-2 at 24-months PTA. To explore the correlation between the two tests we used Spearman’s rho. Bland Altman plots were used to detect if there were systematic differences between the measurements. Receiver-operating characteristics curves were used to calculate area under the curve as an estimate of diagnostic accuracy of the AIMS and the PDMS- with respect to motor outcome at 24 months. Results The correlation between the AIMS and the PDMS-2 (total motor and locomotion subscale), at 6 months, was r = 0.44 and r = 0.76, and at 12 months r = 0.56 and r = 0.80 respectively. The predictive validity for atypical motor function at 24 months, assessed using the area under the curve at 6- and at 12- months, was for the AIMS 0.87 and 0.86, respectively, and for the PDMS-2 locomotion subscale 0.82 and 0.76 respectively. Conclusion The correlation between the AIMS and the PDMS-2 locomotion subscale, at 6- and 12- months PTA, was good to excellent in a group of infants born preterm in Norway. And the AIMS and the locomotion subscale of the PDMS-2 were equally good predictors for atypical motor outcomes at 24 months PTA. These findings indicate that the AIMS and the locomotion subscale of the PDM-2, could be used interchangeable when assessing motor development in infants at 6- or 12 months of age. Trial registration ClinicalTrials.gov NCT01089296.https://doi.org/10.1186/s12887-023-04402-6Motor function assessmentPreterm infantsValidity study
spellingShingle Tordis Ustad
Merethe Brandal
Suzann K. Campbell
Gay L. Girolami
Charlotte Sinding-Larsen
Gunn Kristin Øberg
Concurrent and predictive validity of the Alberta Infant Motor Scale and the Peabody Developmental Motor Scales-2 administered to infants born preterm in Norway
BMC Pediatrics
Motor function assessment
Preterm infants
Validity study
title Concurrent and predictive validity of the Alberta Infant Motor Scale and the Peabody Developmental Motor Scales-2 administered to infants born preterm in Norway
title_full Concurrent and predictive validity of the Alberta Infant Motor Scale and the Peabody Developmental Motor Scales-2 administered to infants born preterm in Norway
title_fullStr Concurrent and predictive validity of the Alberta Infant Motor Scale and the Peabody Developmental Motor Scales-2 administered to infants born preterm in Norway
title_full_unstemmed Concurrent and predictive validity of the Alberta Infant Motor Scale and the Peabody Developmental Motor Scales-2 administered to infants born preterm in Norway
title_short Concurrent and predictive validity of the Alberta Infant Motor Scale and the Peabody Developmental Motor Scales-2 administered to infants born preterm in Norway
title_sort concurrent and predictive validity of the alberta infant motor scale and the peabody developmental motor scales 2 administered to infants born preterm in norway
topic Motor function assessment
Preterm infants
Validity study
url https://doi.org/10.1186/s12887-023-04402-6
work_keys_str_mv AT tordisustad concurrentandpredictivevalidityofthealbertainfantmotorscaleandthepeabodydevelopmentalmotorscales2administeredtoinfantsbornpreterminnorway
AT merethebrandal concurrentandpredictivevalidityofthealbertainfantmotorscaleandthepeabodydevelopmentalmotorscales2administeredtoinfantsbornpreterminnorway
AT suzannkcampbell concurrentandpredictivevalidityofthealbertainfantmotorscaleandthepeabodydevelopmentalmotorscales2administeredtoinfantsbornpreterminnorway
AT gaylgirolami concurrentandpredictivevalidityofthealbertainfantmotorscaleandthepeabodydevelopmentalmotorscales2administeredtoinfantsbornpreterminnorway
AT charlottesindinglarsen concurrentandpredictivevalidityofthealbertainfantmotorscaleandthepeabodydevelopmentalmotorscales2administeredtoinfantsbornpreterminnorway
AT gunnkristinøberg concurrentandpredictivevalidityofthealbertainfantmotorscaleandthepeabodydevelopmentalmotorscales2administeredtoinfantsbornpreterminnorway